Cornerstone Search Group has been retained by a fast-growing, late-stage, multi-asset, rare disease biotech with a very strong cash position, $1Bn+ market cap, and a strong culture set by an experienced executive team. This position will be the company’s inaugural Vice President (Head) of Market Access, and as such will build the US Market Access organization from scratch (including pricing, contracting, account management, distribution, patient services, etc.) in anticipation of their first launch in the second half of 2024.
DESIRED SKILLS / QUALIFICATIONS / EXPERIENCE / BEHAVIORS:
Our client will consider candidates who can work locally 2-3 days per week in their San Francisco Bay Area office as well as candidates from the US or Canada who would want to work remotely.
Market competitive base salary and annual bonus plus very strong new hire and annual stock awards that attractively feature both stock options and RSUs, both of which vest aggressively. RSUs are unusual for pre-commercial stage biotechs.
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as conﬁdential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.